BackgroundVarying degrees of cortical amyloid deposition are reported in the setting of Parkinsonism with cognitive impairment. We performed a systematic review to estimate the prevalence of Alzheimer disease (AD) range cortical amyloid deposition among patients with Parkinson's disease with dementia (PDD), Parkinson's disease with mild cognitive impairment (PD‐MCI) and dementia with Lewy bodies (DLB). We included amyloid positron emission tomography (PET) imaging studies using Pittsburgh Compound B (PiB).MethodsWe searched the databases Ovid MEDLINE, PubMed, Embase, Scopus, and Web of Science for articles pertaining to amyloid imaging in Parkinsonism and impaired cognition. We identified 11 articles using PiB imaging to quantify cortical a...
The pathological basis for the dementia which occurs in 20 to 40% of patients with idiopathic Parkin...
The aim of this study was to assess the agreement between data on cerebral amyloidosis, derived usin...
Parkinson’s disease (PD) is the second most common neurodegenerative disorder. It is characterized b...
The extent to which Alzheimer neuropathology, particularly the accumulation of misfolded beta-amyloi...
The extent to which Alzheimer neuropathology, particularly the accumulation of misfolded beta-amyloi...
Objective To investigate the association between amyloid deposition or white matter degeneration ...
The extent to which Alzheimer neuropathology, particularly the accumulation of misfolded beta-amyloi...
Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) known as Lewy body dementias ...
Background: Parkinson’s disease (PD) is a progressive neurodegenerative motor disorder. However, non...
Background: Dementia is a common, debilitating feature of late Parkinson’s disease (PD). PD dementia...
Introduction: The biological basis for dementia in Parkinson's Disease (PD) appears to be multifacto...
Background: Dementia in Parkinson's disease (PDD) is common presumably due to combined neuropatholog...
Background: Dementia in Parkinson's disease (PDD) is common presumably due to combined neuropatholog...
Background: In Parkinson's disease, mild cognitive impairment and dementia are associated with α‐sy...
Background: Co-occurrence of β-amyloid (Aβ) pathology has been reported in Parkinson's disease (PD),...
The pathological basis for the dementia which occurs in 20 to 40% of patients with idiopathic Parkin...
The aim of this study was to assess the agreement between data on cerebral amyloidosis, derived usin...
Parkinson’s disease (PD) is the second most common neurodegenerative disorder. It is characterized b...
The extent to which Alzheimer neuropathology, particularly the accumulation of misfolded beta-amyloi...
The extent to which Alzheimer neuropathology, particularly the accumulation of misfolded beta-amyloi...
Objective To investigate the association between amyloid deposition or white matter degeneration ...
The extent to which Alzheimer neuropathology, particularly the accumulation of misfolded beta-amyloi...
Dementia with Lewy bodies (DLB) and Parkinson's disease dementia (PDD) known as Lewy body dementias ...
Background: Parkinson’s disease (PD) is a progressive neurodegenerative motor disorder. However, non...
Background: Dementia is a common, debilitating feature of late Parkinson’s disease (PD). PD dementia...
Introduction: The biological basis for dementia in Parkinson's Disease (PD) appears to be multifacto...
Background: Dementia in Parkinson's disease (PDD) is common presumably due to combined neuropatholog...
Background: Dementia in Parkinson's disease (PDD) is common presumably due to combined neuropatholog...
Background: In Parkinson's disease, mild cognitive impairment and dementia are associated with α‐sy...
Background: Co-occurrence of β-amyloid (Aβ) pathology has been reported in Parkinson's disease (PD),...
The pathological basis for the dementia which occurs in 20 to 40% of patients with idiopathic Parkin...
The aim of this study was to assess the agreement between data on cerebral amyloidosis, derived usin...
Parkinson’s disease (PD) is the second most common neurodegenerative disorder. It is characterized b...